Clinical trials

  • vixarelimab for Ulcerative colitis | Moderate to severe ulcerative colitis
  • trastuzumab deruxtecan for Early breast cancer | HER2-positive early breast cancer | HER2-low early breast cancer
  • OXYGEN for Pulmonary hypertension | Coronary microvascular dysfunction | Hypoxia | Heart failure
  • BELIMUMAB for Immune thrombocytopenia
  • ADALIMUMAB for Crohn's disease | Ulcerative colitis
  • LEVOSIMENDAN for Functional tricuspid regurgitation
  • SODIUM IODIDE (131I) for Metastatic differentiated thyroid carcinoma
  • Cangrelor tetrasodium for Acute ischemic stroke
  • Fluorouracil for Gastroesophageal junction adenocarcinoma (adenocarcinoma of the gastroesophageal junction)
  • INAVOLISIB for Hormone receptor-positive HER2-negative advanced breast cancer (PIK3CA‑mutated)
  • trastuzumab deruxtecan for Unresectable and/or metastatic solid tumors with HER2 activating mutations
  • ferumoxytol for Iron deficiency anemia